1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow HER2 Positive: new trials by email Literature Review of HER2 Positive trials Research Report on HER2 Positive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer Inetetamab + Gemcitabine + Cisplatin ± PD-1/PD-L1 inhibitor - Metastatic Biliary Tract Cancer, HER2 Positive | Phase 4 | Not yet recruiting | Eastern Hepatobiliary Surgery Hospital | 35 | 2025-02-01 | 2025-02-10 |
Biliary Tract Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
Gemcitabine (1)